The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Anthracycline Dose Intensification in Acute Myeloid Leukemia
Open accessAbstract
BACKGROUND: In young adults with acute myeloid leukemia (AML), intensification of the anthracycline dose during induction therapy has improved the rate of complete remission but not of overall survival. We evaluated the use of cytarabine plus either standard-dose or high-dose daunorubicin as induction therapy, followed by intensive consolidation therapy, in inducing complete remission to improve overall survival. METHODS: In this phase 3 randomized trial, we assigned 657 patients between the ages of 17 and 60 years who had untreated AML to receive three once-daily doses of daunorubicin at either the standard dose (45 mg per square meter of body-surface area) or a high dose (90 mg per square meter), combined with seven daily doses of cytarabine (100 mg per square meter) by continuous intravenous infusion. Patients who had a complete remission were offered either allogeneic hematopoietic stem-cell transplantation or high-dose cytarabine, with or without a single dose of the monoclonal antibody gemtuzumab ozogamicin, followed by autologous stem-cell transplantation. The primary end point was overall survival. RESULTS: In the intention-to-treat analysis, high-dose daunorubicin, as compared with a standard dose of the drug, resulted in a higher rate of complete remission (70.6% vs. 57.3%, P<0.001) and improved overall survival (median, 23.7 vs. 15.7 months; P=0.003). The rates of serious adverse events were similar in the two groups. Median follow-up was 25.2 months. CONCLUSIONS: In young adults with AML, intensifying induction therapy with a high daily dose of daunorubicin improved the rate of complete remission and the duration of overall survival, as compared with the standard dose. (ClinicalTrials.gov number, NCT00049517.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues
Swerdlow, S. H. (2017) · Medical Entomology and Zoology · Cited by 12,933
Cheson, B. D., Bennett, J. M., Kopecky, K. J., Büchner, T., Willman, C. L., Estey, E. H., Schiffer, C. A., Doehner, H., Tallman, M. S., Lister, T. A., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.036 · Cited by 2,654
Self-citationCreutzig, U., & Kaspers, G. J. L. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.99.116 · Cited by 2,137
Slovak, M. L., Kopecky, K. J., Cassileth, P. A., Harrington, D. H., Theil, K. S., Mohamed, A., Paietta, E., Willman, C. L., Head, D. R., Rowe, J. M., et al. (2000) · Blood · doi:10.1182/blood.v96.13.4075 · Cited by 1,601
Self-citationIntensive Postremission Chemotherapy in Adults with Acute Myeloid Leukemia
Mayer, R. J., Davis, R. B., Schiffer, C. A., Berg, D. T., Powell, B. L., Schulman, P., Omura, G. A., Moore, J. O., McIntyre, O. R., & Frei, E. (1994) · New England Journal of Medicine · doi:10.1056/nejm199410063311402 · Cited by 1,427
van Dongen, J., Macintyre, E., Gabert, J., Delabesse, E., Rossi, V, Saglio, G., Gottardi, E., Rambaldi, A., Dotti, G., Griesinger, F., et al. (1999) · Leukemia · doi:10.1038/sj.leu.2401592 · Cited by 1,169
Treatment of acute myelocytic leukemia: a study by cancer and leukemia group B
Rai, K., Holland, J., Glidewell, O., Weinberg, V, Brunner, K., Obrecht, J., Preisler, H., Nawabi, I., Prager, D., Carey, R., et al. (1981) · Blood · doi:10.1182/blood.v58.6.1203.1203 · Cited by 532
Wiernik, P., Banks, P., Case, D. J., Arlin, Z., Periman, P., Todd, M., Ritch, P., Enck, R., & Weitberg, A. (1992) · Blood · doi:10.1182/blood.v79.2.313.313 · Cited by 462
Rowe, J., Andersen, J., Mazza, J., Bennett, J., Paietta, E., Hayes, F., Oette, D., Cassileth, P., Stadtmauer, E., & Wiernik, P. (1995) · Blood · doi:10.1182/blood.v86.2.457.bloodjournal862457 · Cited by 443
Self-citationWeick, J., Kopecky, K., Appelbaum, F., Head, D., Kingsbury, L., Balcerzak, S., Bickers, J., Hynes, H., Welborn, J., Simon, Sr., et al. (1996) · Blood · doi:10.1182/blood.v88.8.2841.bloodjournal8882841 · Cited by 411
Büchner, T., Urbanitz, D., Hiddemann, W., Rühl, H., Ludwig, W. D., Fischer, J., Aul, H. C., Vaupel, H. A., Kuse, R., & Zeile, G. (1985) · Journal of Clinical Oncology · doi:10.1200/jco.1985.3.12.1583 · Cited by 362
Preisler, H. D., Davis, R., Kirshner, J. J., Dupre, E., Richards, F., Hoagland, H. C., Kopel, S., Levy, R., Carey, R. W., & Schulman, P. (1987) · PubMed · doi:10.1182/blood.v69.5.1441.1441 · Cited by 294
Arlin, Z. A., Case, D. C., Moore, J. L., Wiernik, P. H., Feldman, E. J., Saletan, S., Desai, P., Sia, L. L., & Cartwright, K. J. (1990) · PubMed · Cited by 197
Noguera, N., Breccia, M., Divona, M., Diverio, D., Costa, V, De Santis, S., Avvisati, G., Pinazzi, M., Petti, M., Mandelli, F., et al. (2002) · Leukemia · doi:10.1038/sj.leu.2402723 · Cited by 183
ROUP, T. H. A. C. O. G. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00948.x · Cited by 162
Kolitz, J. E., George, S. L., Dodge, R. K., Hurd, D. D., Powell, B. L., Allen, S. L., Vélez-García, E., Moore, J. O., Shea, T. C., Hoke, E. E., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.11.106 · Cited by 150
Long-term survival in acute myeloid leukemia: The Eastern Cooperative Oncology Group experience
Bennett, J. M., Young, M. L., Andersen, J. W., Cassileth, P. A., Tallman, M. S., Paietta, E. M., Wiernik, P. H., & Rowe, J. M. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19971201)80:11+<2205::aid-cncr7>3.0.co;2-g · Cited by 128
Self-citationLong-term survival in acute myeloid leukemia: the Eastern Cooperative Oncology Group experience.
Bennett, J. M., Young, M. L., Andersen, J. W., et al. (1997) · PubMed · Cited by 111
Self-citationSchiller, G. J., Gajewski, J., Territo, M., et al. (1992) · Blood · doi:10.1182/blood.v80.12.2977.2977 · Cited by 94
Bishop, J. F., Matthews, J. P., Young, G. A. R., Bradstock, K. F., & Lowenthal, R. M. (1998) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199809092687 · Cited by 59
Schiller, G. J., Gajewski, J., Nimer, S. D., et al. (1992) · British Journal of Haematology · doi:10.1111/j.1365-2141.1992.tb08203.x · Cited by 49
(1999) · Leukemia · doi:10.1038/sj/leu/2401592 · Cited by 34
Cited by
Döhner, H., Estey, E., Grimwade, D., Amadori, S., Appelbaum, F. R., Büchner, T., Dombret, H., Ebert, B. L., Fenaux, P., Larson, R. A., et al. (2017) · Blood · doi:10.1182/blood-2016-08-733196 · Cited by 5,775
Self-citationFigueroa, M. E., Abdel-Wahab, O., Lu, C., Ward, P. S., Patel, J., Shih, A., Li, Y., Bhagwat, N., Vasanthakumar, A., Fernandez, H. F., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.11.015 · Cited by 2,766
Self-citationPrognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
Patel, J. P., Gönen, M., Figueroa, M. E., Fernandez, H., Sun, Z., Racevskis, J., Van Vlierberghe, P., Dolgalev, I., Thomas, S., Aminova, O., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112304 · Cited by 1,946
Self-citation‘Acute myeloid leukemia: a comprehensive review and 2016 update’
De Kouchkovsky, I., & Abdul-Hay, M. (2016) · Blood Cancer Journal · doi:10.1038/bcj.2016.50 · Cited by 1,317
Castaigne, S., Pautas, C., Terré, C., Raffoux, E., Bordessoule, D., Bastie, J.-N., Legrand, O., Thomas, X., Turlure, P., Reman, O., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60485-1 · Cited by 1,015
Metadata
- Authors
- Fernandez, H. F., Sun, Z., Yao, X., Litzow, M. R., Luger, S. M., Paietta, E. M., Racevskis, J., Dewald, G. W., Ketterling, R. P., Bennett, J. M., Rowe, J. M., Lazarus, H. M., & Tallman, M. S.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2009-09-24
- Volume
- 361
- Issue
- 13
- Pages
- 1249-1259
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2069448515
- Cited by
- 919
- References
- 23
- FWCI
- 38.23
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.